Methotrexate is effective in preventing acute and potentially chronic renal allograft rejection.
Michael
B
B
Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania 19107-5098.
Francos
G C
GC
Burke
J F
JF
Gaughan
W I
WI
D000208:Acute Disease; D000328:Adult; D002908:Chronic Disease; D003404:Creatinine / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D012083:Renin / Q000097:blood; D013997:Time Factors; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D003404:Creatinine; D012083:Renin; D008727:Methotrexate